Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Hot Products

China NMPA Accepts IND Application for Eftansomatropin Pivotal Trial in Pediatric Patients with Growth Hormone Deficiency

prnasiaAugust 04, 2020

Tag: NMPA , Pediatric Patients , Growth Hormone Deficiency

PharmaSources Customer Service